http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002045626-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40a92325286ca98dbffa06d2c67ed064 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 |
| filingDate | 2001-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f53dc60718fdc32d06a4d194c29b9e0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dde6f469a19e239c77e6f87559fa456f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bba27a2809a1ab6bf3f2ec8b35bfc66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d928de06d403630e5023d3fbcfd0beb6 |
| publicationDate | 2002-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2002045626-A1 |
| titleOfInvention | Benzylpiperazinyl and piperidinyl ethanone derivatives: dopamine receptor subtype specific ligands |
| abstract | Disclosed are compounds of the formula: n n n or pharmaceutically acceptable addition salts thereof wherein: n Y represents oxygen or sulfur; Z is nitrogen or CH; n R 1 , R 2 and R 3 independently represent organic or inorganic substituents; n R 4 and R 4 ′ independently represent hydrogen, alkyl or form a ring with the atom to which they are attached; n R 5 represents hydrogen, alkyl, alkoxy, or alkylthio, and R 6 represents hydrogen or alkyl; or R 5 and R 6 form a ring together with the atoms to which they are attached; and n R 7 , R 8 , R 9 , R 10 , and R 11 independently represent hydrogen or alkyl, n which compounds are useful for the treatment and/or prevention of neuropsychological disorders including, but not limited to, schizophrenia, mania, dementia, depression, anxiety, compulsive behavior, substance abuse, Parkinson-like motor disorders and motion disorders related to the use of neuroleptic agents. |
| priorityDate | 1998-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 427.